Decreased bone density and bone strength in a mouse model of severe factor VIII deficiency

British Journal of Haematology

Volumn 158, Issue 1, 2012, Pages 140-143

  Liel, Meghan S ^a,b   Greenberg, Daniel L ^a   Recht, Michael ^a   Vanek, Chaim ^a   Klein, Robert F ^a,b   Taylor, Jason A ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Bone density; Factor VIII; Haemophilia; Osteoporosis

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; THROMBIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE DENSITY; BONE FRAGILITY; BONE MASS; BONE STRENGTH; CORTICAL BONE; HEMOPHILIA A; LETTER; LOCOMOTION; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BONE DENSITY; DISEASE MODELS, ANIMAL; HEMOPHILIA A; HUMANS; MALE; MICE; MICE, KNOCKOUT;

EID: 84862246230     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09101.x     Document Type: Letter

References (10)

1. Barnes, C., Wong, P., Egan, B., Speller, T., Cameron, F., Jones, G., Ekert, H. & Monagle, P. (2004) Reduced bone density among children with severe hemophilia. Pediatrics, 114, 177-181.
2. Bi, L., Sarkar, R., Naas, T., Lawler, A.M., Pain, J., Shumaker, S.L., Bedian, V. & Kazazian, H.H. (1996) Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood, 88, 3446-3450.
3. Dargaud, Y., Béguin, S., Lienhart, A., Al Dieri, R., Trzeciak, C., Bordet, J.C., Hemker, H.C. & Negrier, C. (2005) Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thrombosis and Haemostasis, 93, 475-480.
4. Ettinger, B., Black, D.M., Mitlak, B.H., Knickerbocker, R.K., Nickelsen, T., Genant, H.K., Christiansen, C., Delmas, P.D., Zanchetta, J.R., Stakkestad, J., Glüer, C.C., Krueger, K., Cohen, F.J., Eckert, S., Ensrud, K.E., Avioli, L.V., Lips, P. & Cummings, S.R. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene (MORE) Investigators. Journal of the American Medical Association, 282, 637-645.
5. Gerstner, G., Damiano, M.L., Tom, A., Worman, C., Schultz, W., Recht, M. & Stopeck, A.T. (2009) Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia, 15, 559-565.
6. Gubner, N.R., Wilhelm, C.J., Phillips, T.J. & Mitchell, S.H. (2010) Strain differences in behavioral inhibition in a Go/No-go task demonstrated using 15 inbred mouse strains. Alcoholism Clinical and Experimental Research, 34, 1353-1362.
7. Klein, R.F., Shea, M., Gunness, M.E., Pelz, G.B., Belknap, J.K. & Orwoll, E.S. (2001) Phenotypic characterization of mice bred for high and low peak bone mass. Journal of Bone and Mineral Research, 16, 63-71.
8. Mackie, E.J., Loh, L.H., Sivagurunathan, S., Uaesoontrachoon, K., Yoo, H.J., Wong, D., Georgy, S.R. & Pagel, C.N. (2008) Protease-activated receptors in the musculoskeletal system. The International Journal of Biochemistry and Cell Biology, 40, 1169-1184.
9. Wallny, T.A., Scholz, D.T., Oldenburg, J., Nicolay, C., Ezziddin, S., Pennekamp, P.H., Stoffel-Wagner, B. & Kraft, C.N. (2007) Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia, 13, 79-84.
10. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. & Suda, T. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America, 95, 3597-3602.